Point72 (Difc) LTD Taysha Gene Therapies, Inc. Transaction History
Point72 (Difc) LTD
- $2.44 Trillion
- Q1 2025
A detailed history of Point72 (Difc) LTD transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 15,528 shares of TSHA stock, worth $45,031. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,528Holding current value
$45,031% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TSHA
# of Institutions
127Shares Held
151MCall Options Held
70KPut Options Held
4.7K-
Avoro Capital Advisors LLC New York, NY20MShares$58 Million0.45% of portfolio
-
Rtw Investments, LP New York, NY18.8MShares$54.5 Million0.43% of portfolio
-
Morgan Stanley New York, NY16.8MShares$48.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$34.1 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA10.9MShares$31.5 Million0.31% of portfolio
About Taysha Gene Therapies, Inc.
- Ticker TSHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,359,500
- Market Cap $140M
- Description
- Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...